Changes Nov. 30, 2020
The following is a list of changes on monitored regulatory lists which occurred between Nov. 11, 2020 and Nov. 30, 2020.
Legend
- regulatory records added to the list
- regulatory records removed from the list
- changed regulatory records
For changed records, you can see the history of changes by following the link to the corresponding regulatory record.
Biocidal active substances
- 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (Propiconazole)
- 3-iodo-2-propynylbutylcarbamate (IPBC)
- Alkyl (C12-16) dimethylbenzyl ammonium chloride (ADBAC/BKC (C12-16))
- Alkyl (C12-16) dimethylbenzyl ammonium chloride (ADBAC/BKC (C12-16))
- Alkyl (C12-16) dimethylbenzyl ammonium chloride (ADBAC/BKC (C12-16))
- Boric acid
- Brodifacoum
- Bromadiolone
- Didecyldimethylammonium chloride(DDAC)
- Didecyldimethylammonium chloride(DDAC)
- Difenacoum
- Hydrochloric acid
- Iodine
- Iodine
- Lactic acid
- Peracetic acid
- Peracetic acid
- Peracetic acid
- Peroxyoctanoic acid
- Peroxyoctanoic acid
- Peroxyoctanoic acid
- Polyvinylpyrrolidone iodine
- Polyvinylpyrrolidone iodine
- Sodium benzoate
- alphachloralose
- imidacloprid
- tebuconazole
Registry of CLH intentions until outcome
- (1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate
- (RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate; fosthiazate (ISO)
- 1,2-benzisothiazol-3(2H)-one
- 1,4-Benzenediamine, N,N'-mixed Ph and tolyl derivs.
- 1-phenylethan-1-one (1-phenylethylidene)hydrazone
- 1-vinylimidazole
- 2,2',6,6'-tetrabromo-4,4'-isopropylidenediphenol
- 2,2'-ethylenedioxydiethyl dimethacrylate
- 2,3,5,6-tetrafluoro-4-(methoxymethyl)benzyl (1<I>R</I>,3<I>R</I>)-2,2-dimethyl-3-[(1<I>Z</I>)-prop-1-en-1-yl] cyclopropanecarboxylate;epsilon-metofluthrin
- 2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether
- 2-ethylhexanoic acid, manganese salt
- 2-ethylhexanoic acid, molybdenum salt
- 2-ethylhexanoic acid, zirconium salt
- 2-methyl-2H-isothiazol-3-one
- 3,6,9-trioxaundecamethylene dimethacrylate
- 9-[2-(ethoxycarbonyl)phenyl]-3,6-bis(ethylamino)-2,7-dimethylxanthylium chloride
- Barium bis(2-ethylhexanoate)
- Benzophenone
- Calcium bis(2-ethylhexanoate)
- Daminozide
- Dibenzoyl peroxide
- Dibutyltin maleate
- Dibutyltin oxide
- Dimethyl propylphosphonate
- Diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide
- Exo-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl acrylate
- Hexanoic acid, 2-ethyl-, zinc salt, basic
- Metal salts of 2-ethylhexanoic acid
- Multi-Walled Carbon Nanotubes (fibres fulfilling the WHO definition: diameter < 3 µm, fibre length > 5 μm and aspect ratio ≥ 3:1, with a diameter > xx nm)
- Potassium 2-ethylhexanoate
- Silanamine, 1,1,1-trimethyl-N-(trimethylsilyl)-, hydrolysis products with silica
- Sodium 2-ethylhexanoate
- Tellurium dioxide
- Tetramethrin
- Toluene-4-sulphonohydrazide
- Zinc bis(2-ethylhexanoate)
- acetamiprid (ISO); (1E)-N-[(6-chloropyridin-3-yl)methyl]-N'-cyano-N-methylethanimidamide; (E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine
- amisulbrom (ISO); 3-(3-bromo-6-fluoro-2-methylindol-1-ylsulfonyl)-N,N-dimethyl-1H-1,2,4-triazole-1-sulfonamide
- beta-cyfluthrin (ISO); reaction mass of rel-(R)-cyano(4-fluoro-3-phenoxyphenyl)methyl (1S,3S)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate and rel-(R)-cyano(4-fluoro-3-phenoxyphenyl)methyl (1S,3R)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate (ratio 1:2)
- clofentezine (ISO); 3,6-bis(o-chlorophenyl)-1,2,4,5-tetrazine
- clothianidin (ISO); (E)-1-(2-chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine
- fluopicolide (ISO); 2,6-dichloro-N-[3-chloro-5-(trifluoromethyl)-2-pyridylmethyl]benzamide
- flutianil (ISO); (2Z)-{[2-fluoro-5-(trifluoromethyl)phenyl]thio}[3-(2-methoxyphenyl)-1,3-thiazolidin-2-ylidene]acetonitrile
- isopropyl (2E,4E,7S)-11-methoxy-3,7,11-trimethyldodeca-2,4-dienoate;S-methoprene
- mesosulfuron-methyl (ISO); methyl 2-[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-α-(methanesulfonamido)-p-toluate
- pinoxaden (ISO); 8-(2,6-diethyl-4-methylphenyl)-7-oxo-1,2,4,5-tetrahydro-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl 2,2-dimethylpropanoate
- pyroxsulam (ISO);N-(5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-2-methoxy-4-(trifluoromethyl) pyridine-3-sulfonamide
- reaction mass of 1-[2-(2-aminobutoxy)ethoxy]but-2-ylamine and 1-({[2-(2-aminobutoxy)ethoxy]methyl}propoxy)but-2-ylamine
- sodium methyl [(4-aminophenyl)sulphonyl]carbamate; asulam-sodium
- spirodiclofen (ISO);3-(2,4-dichlorophenyl)-2-oxo-1-oxaspiro[4.5]dec-3-en-4-yl 2,2-dimethylbutyrate
- transfluthrin (ISO); 2,3,5,6-tetrafluorobenzyl (1R,3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
- α-cyano-4-fluoro-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
Registry of restriction intentions
- 1-Butanaminium, N,N,N-tributyl-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid
- 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, cesium salt (1:1)
- 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd. With pyrrolidine (1:1)
- 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd. with N,N-diethylethanamine (1:1)
- 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd.with 2-methyl-2-propanamine (1:1)
- 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, gallium salt (9CI)
- 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, lithium salt (1:1)
- 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, neodymium(3+) salt (3:1)
- 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, scandium(3+) salt (3:1)
- 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, sodium salt
- 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, yttrium(3+) salt (3:1)
- 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, zinc salt
- 4,4'-isopropylidenediphenol
- Ammonium perfluorohexane-1-sulphonate
- Beta-Cyclodextrin, compd. with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid ion(1-)(1:1)
- Calcium cyanamide
- Dibenzo[k,n][1,4,7,10,13]tetraoxathiacyclopentadecinium, 19-[4-(1,1-dimethylethyl)phenyl]-6,7,9,10,12,13-hexahydro-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
- Ethanaminium, N,N,N-triethyl-, salt with1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:1)
- Ethanaminium, N-[4-[[4-(diethylamino)phenyl][4-(ethylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
- Gamma-Cyclodextrin, compd. with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid ion(1-)(1:1)
- Iodonium, bis[(1,1-dimethylethyl)phenyl]-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:1) (9CI)